Medical Condition News

RSS

Nationwide STEMI rates drop, reveals Vanderbilt study

The most emergent form of heart attacks is decreasing nationwide, but this declining incidence could affect emergency departments' quality and timeliness of care.

18 Nov 2014

Scientists find cells responsible for memory problems after sleep loss

Sleep is a critical period for memory consolidation, and most people don't get enough. Research has shown that even brief periods of sleep deprivation can lead to deficits in memory formation.

18 Nov 2014

Common anti-malaria medicine could have significant impact on colorectal cancer

Medical experts say a common malaria drug could have a significant impact on colorectal cancer providing a cheap adjunct to current expensive chemotherapy.

18 Nov 2014

3SBio enters into exclusive license agreement with PharmAbcine for Tanibirumab

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced it has entered into an exclusive license with PharmAbcine, Inc. for the development, manufacturing and marketing of Tanibirumab, an anti-VEGFR2/KDR antibody for cancer in the territory of Greater China (including Mainland China, Taiwan, Hong Kong and Macau) and several emerging countries, including Thailand, Brazil and Russia.

18 Nov 2014

Scientists identify how ADAR1 gene mutation can lead to diseases

Scientists have discovered how a gene mutation can lead to diseases that occur when the immune system attacks the body by mistake.

18 Nov 2014

Investigational treatment shows promise against Marfan syndrome

An investigational treatment for Marfan syndrome is as effective as the standard therapy at slowing enlargement of the aorta, the large artery of the heart that delivers blood to the body, new research shows. The findings indicate a second treatment option for Marfan patients, who are at high risk of sudden death from tears in the aorta.

18 Nov 2014

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Health Canada is aware of and will be reviewing new evidence on the safety of long-term use of the prescription blood-thinners clopidogrel (Plavix) and prasugrel (Effient).

18 Nov 2014

Study identifies new gene for progressive form of epilepsy

A study led by researchers at University of Helsinki, Finland and Universities of Melbourne and South Australia has identified a new gene for a progressive form of epilepsy. The findings of this international collaborative effort have been published today, 17 November 2014, in Nature Genetics.

18 Nov 2014

University of Sheffield scientists find significant rise in serious heart infection

Scientists at the University of Sheffield have identified a significant rise in the number of people diagnosed with a serious heart infection alongside a large fall in the prescribing of antibiotic prophylaxis to dental patients.

18 Nov 2014

New research suggests potential role for MEK inhibitors in type 2 diabetes

A research team led by Brigham and Women's Hospital and Dana-Farber Cancer Institute has uncovered surprising new findings that underscore the role of an important signaling pathway, already known to be critical in cancer, in the development of type 2 diabetes.

18 Nov 2014

Cigna Foundation awards World of Difference grant to improve heart healthy behaviors in women

When it comes to hearts, men and women are not created equally. Women who have experienced a heart attack have a higher risk of a subsequent heart attack, or death, compared to men, according to the American Heart Association.

18 Nov 2014

Research finding could have major implications for diabetes treatment

Harvard Stem Cell Institute researchers, representing five Harvard departments and affiliated institutions as well as the Massachusetts Institute of Technology, have demonstrated that adult cells, reprogrammed into another cell type in a living animal, can remain functional over a long period.

18 Nov 2014

Omega-3 fatty acids decrease risk of getting heart disease

Increasing the amount of omega-3s in your diet, whether from fish or flax, will likely decrease your risk of getting heart disease, according to Penn State nutritionists.

18 Nov 2014

Edison announces initiation of full coverage on ADRs of DBV Technologies

Edison Investment Research, a leading international investment research firm, announces the initiation of full coverage on the US-listed ADRs of DBV Technologies, the French allergy company focused on peanut allergy.

18 Nov 2014

FDA grants Orphan Drug Designation to Juno's JCAR015 leukemia T cell product candidate

Juno Therapeutics, Inc. announced today that the FDA has granted Orphan Drug Designation to its JCAR015 chimeric antigen receptor product candidate. The designation was granted for treatment of acute lymphoblastic leukemia. JCAR015 Phase I trials are currently underway at Juno's collaboration partner, Memorial Sloane Kettering Cancer Center.

18 Nov 2014

BMI plays role in rheumatoid arthritis patients' ability to achieve sustained remission

A study by Hospital for Special Surgery researchers finds that body mass index (BMI) plays a role in rheumatoid arthritis (RA) patients' ability to achieve a sustained remission. Looking at patients who had received an RA diagnosis within the past 12 months, investigators found that those who were significantly underweight or overweight/obese were the least likely to remain in remission.

18 Nov 2014

Researchers discover second protein associated with membranous nephropathy

An international team of researchers from France, Germany, and the US have identified a protein that turns a person's immune system against itself in a form of kidney disease called membranous nephropathy (MN). The new research was presented at ASN Kidney Week 2014 in Philadelphia and published online in the New England Journal of Medicine.

18 Nov 2014

Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

Researchers from Allina Health and the Minneapolis Heart Institute Foundation have presented on the results and implications of The Heart of New Ulm Project on heart disease risk factors at the American Heart Association Scientific Sessions in Chicago, Ill.

18 Nov 2014

New oral medication shows promise in treating fibromyalgia

A new oral medication known as IMC-1, developed by Innovative Med Concepts, proved highly effective at reducing pain and other symptoms of fibromyalgia (FM) in patients in a recent clinical trial.

18 Nov 2014

Pros and cons of medical marijuana to be discussed at Queensland Epilepsy Symposium

The pros and cons of medical marijuana is a discussion focus at the fifth annual Queensland Epilepsy Symposium, Epilepsy – On the Horizon.

18 Nov 2014

Medical Condition News

Nationwide STEMI rates drop, reveals Vanderbilt study

Scientists find cells responsible for memory problems after sleep loss

Common anti-malaria medicine could have significant impact on colorectal cancer

3SBio enters into exclusive license agreement with PharmAbcine for Tanibirumab

Scientists identify how ADAR1 gene mutation can lead to diseases

Investigational treatment shows promise against Marfan syndrome

Health Canada to review evidence on the safety of long-term use of prescription blood-thinners

Study identifies new gene for progressive form of epilepsy

University of Sheffield scientists find significant rise in serious heart infection

New research suggests potential role for MEK inhibitors in type 2 diabetes

Cigna Foundation awards World of Difference grant to improve heart healthy behaviors in women

Research finding could have major implications for diabetes treatment

Omega-3 fatty acids decrease risk of getting heart disease

Edison announces initiation of full coverage on ADRs of DBV Technologies

FDA grants Orphan Drug Designation to Juno's JCAR015 leukemia T cell product candidate

BMI plays role in rheumatoid arthritis patients' ability to achieve sustained remission

Researchers discover second protein associated with membranous nephropathy

Researchers present results of The Heart of New Ulm Project at AHA Scientific Sessions

New oral medication shows promise in treating fibromyalgia

Pros and cons of medical marijuana to be discussed at Queensland Epilepsy Symposium

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News